Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.22
Delayed Data
As of Feb 24
 -0.02 / -0.89%
Today’s Change
1.93
Today|||52-Week Range
3.84
+4.72%
Year-to-Date
Argos Plummets 72%, Leads Biotech Movers
Feb 22 / TheStreet.com - Paid Partner Content
8 High-Yield Stocks With Falling Prices
Feb 21 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close2.24
Today’s open2.22
Day’s range2.18 - 2.26
Volume914,677
Average volume (3 months)2,333,438
Market cap$367.5M
Dividend yield9.01%
Data as of 3:59pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-74.34%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.01%
P/E ratio2.1
Price/Sales0.99
Price/Book0.52

Competitors

 Today’s
change
Today’s
% change
MCRBSeres Therapeutics I...-0.10-1.09%
RXDXIgnyta Inc-0.40-4.40%
NVAXNovavax Inc0.000.00%
BTXBioTime Inc-0.12-3.51%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)$0.09
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts


Search for Jobs